Generic Name and Formulations:
Ciclopirox 0.77%; crm; lotion.
Medimetriks Pharmaceuticals, Inc.
Indications for LOPROX:
Tinea pedis, t. cruris, t. corporis, t. versicolor. Cutaneous candidiasis.
Adults and Children:
<10yrs: not recommended. ≥10yrs: Apply and gently massage into affected and surrounding areas twice daily for up to 4 wks.
Avoid eyes, mucous membranes, occlusion. Discontinue if irritation or sensitization occurs. Pregnancy (Cat.B). Nursing mothers.
Pruritus, burning sensation, contact dermatitis.
Crm—15g, 30g, 90g; Lotion—30mL, 60mL; Gel—30g, 45g; Shampoo—120mL
Sign Up for Free e-newsletters
- Study Finds Association Between Folate Intake and Risk of Cutaneous Melanoma
- Melanoma Outcomes Improved With Nivolumab Alone or Plus Ipilimumab
- Encorafenib, Binimetinib Combination Receives FDA Approval for Mutation-Positive Melanoma
- Certain Risk Factors May Decrease Overall Survival in Pediatric B-NHL
- Oral Contraceptive Use May Not Be Associated With Increased Melanoma Risk
- Implementing an Ambulatory Adherence Program May Improve Oral Anticancer Medications Compliance
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- Managing Dyspnea With Fentanyl in Patients With Cancer at End of Life
- CALM: A Depression Intervention for Cancer Patients at the End of Life
- High BMI Among Premenopausal Women May Improve Risk for Breast Cancer
- Carfilzomib Benefits May Outweigh Cardiovascular Risk in Multiple Myeloma
- Patient Interest in Melanoma Genetic Risk Testing is Fairly High
- Genetic Link Between Depression and Breast Cancer Remains Unclear
- Bariatric Surgery Reduced Risk of Some Cancers in Obese Patients
- Bleeding Disorder Treatments: Hemophilia A
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|